Leuprotime 22.5mg Injection

Leuprotime 22.5mg Injection contains the active ingredient Leuprolide acetate, a Gonadotropin Releasing Hormone (GnRH) agonist. It is used to treat prostate cancer in men, hormone-responsive breast cancer in women, endometriosis (growth of uterine tissue outside the uterus), and uterine fibroids (noncancerous uterine growths) in women. The injection is also indicated for premature puberty, characterised by early physical development in children due to hormonal imbalances.

Do not use this injection if you are allergic to Leuprotime 22.5mg Injection or any of its ingredients, including Goserelin and Triptorelin. Inform your physician prior to treatment if you have liver or kidney impairment. Notify your doctor if you have undiagnosed abnormal uterine bleeding. This medicine is contraindicated in pregnancy or planned pregnancy. During treatment, existing symptoms may temporarily worsen due to increased sex steroid levels in the body; discuss this with your physician. Report any progressive brain tumour in your child to your doctor. Before starting treatment, inform your doctor of underlying medical conditions including diabetes, seizures, heart problems with chest pain, irregular heartbeats, depression, or increased risk of osteoporosis. This medicine is not recommended for patients with abnormal vaginal bleeding. Women of childbearing age should use non-hormonal contraceptive methods during Leuprotime 22.5mg Injection treatment. Notify your doctor if you are a man with urinary obstruction or have undergone testicular removal. Inform your doctor if you experience spinal cord pressure, urinary disorders, or haematuria (blood in the urine).

The Leuprotime 22.5mg Injection is used in the treatment of the following: Prostate cancer Hormone-responsive breast cancer in perimenopausal (around menopause) women Endometriosis (a painful illness in which the tissue that normally lines the inside of the uterus grows outside of your uterus) Central precocious puberty (a child’s body begins to change into an adult too soon, caused by a release of certain hormones)

Leuprotime 22.5mg Injection decreases testosterone or estrogen production, depending on the treated condition. This helps to slow the growth of cancer cells, reduce the size of uterine fibroids, and alleviate the symptoms of endometriosis and early onset of puberty.

Leuprotime 22.5mg Injection is usually administered in the arm, thigh or abdomen. If this injection is recommended for you, it will be given by a healthcare professional. Do not self-administer. Your physician will choose the dosage and administration frequency based on your medical condition because it differs for each person.

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious side effects of Leuprotime 22.5mg Injection are: Severe rash, itching Shortness or difficulty in breath Cough with blood Pulmonary embolism Severe headache Common side effects of Leuprotime 22.5mg Injection are: Altered blood sugar and cholesterol levels Injection site reactions Loss of appetite Abnormal liver function Swelling in the ankle or hand Difficulty sleeping, headache Mood swings, depression Weight changes Nausea, vomiting Vaginal dryness, bleeding Loss of interest in sexual intercourse Hot flushes Bone pain, muscle weakness Breast tenderness

During the treatment of breast cancer with Leuprotime 22.5mg Injection, it is recommended to undergo regular checkups every three months in combination with an aromatase inhibitor. Do not receive this injection if you experience any abnormal vaginal bleeding. Consult your doctor immediately if you or your child is suffering from a headache even after treating it with painkillers, vision problems, buzzing, or ringing in the ear. If you have diabetes, ask your doctor to monitor your glucose and blood sugar levels regularly. Before starting, inform your doctor if you are still menstruating.